[Use of serological markers in the diagnosis and prognosis of chronic viral hepatitis].
D000956:Antigens, Viral / Q000032:analysis*; D006528:Carcinoma, Hepatocellular / Q000209:etiology; D002353:Carrier State / Q000097:blood / Q000175:diagnosis / Q000276:immunology; D002908:Chronic Disease; D014943:Global Health; D006508:Hepatitis Antibodies / Q000032:analysis*; D006518:Hepatitis Viruses / Q000276:immunology / Q000502:physiology / Q000648:ultrastructure; D006521:Hepatitis, Chronic / Q000097:blood* / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D006525:Hepatitis, Viral, Human / Q000097:blood* / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D008103:Liver Cirrhosis / Q000209:etiology; D008113:Liver Neoplasms / Q000209:etiology; D011379:Prognosis; D011446:Prospective Studies; D013256:Steroids / Q000627:therapeutic use; D013997:Time Factors; D014779:Virus Replication
D000956:Antigens, Viral; D006508:Hepatitis Antibodies; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D013256:Steroids
Utilidad de los marcadores serológicos en el diagnóstico y pronóstico de la hepatitis crónica por virus.